The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...

US-based diagnostic software company Arkstone Medical Solutions has partnered with Peruvian medical technology company Neslab ...

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

Antibiotics are often thought of as an easy cure to bacterial infections, but they could be fueling an urgent public health ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

Researchers have used artificial intelligence to identify 25 new protein compounds that can kill bacteria and fungi, ...

A groundbreaking cannabinoid-based antimicrobial, Silvanex, fights drug-resistant infections with a synergy of silver, CBC ...

TI Medical, Healthium Medtech Limited, Meril Life Sciences Pvt Ltd, Unilene, Johnson, Boz Medical, Futura Surgicare Pvt ...

Antimicrobial resistance (AMR) happens when germs, like fungi and bacteria, develop the ability to defeat the drugs that are ...

Addresses the significant threat of antimicrobial resistance.

Disperazol Pharma, a leading biotechnology firm that develops compounds that dismantle biofilms of critical Gram—negative pathogens, today announced that it has joined the AMR Industry Alliance. AMR ...

The College of Veterinary Medicine is hosting a public health conference in the Stewart Center about antimicrobial resistance ...